Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TNBC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04725331
What this trial is testing

A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors

Who this might be right for
Metastatic CancerSoft Tissue SarcomaMerkel Cell Carcinoma+3 more
Transgene 31
Early research (Phase 1)Active Not RecruitingNCT05174637
What this trial is testing

FDA018-ADC in Patients With Advanced Solid Tumors

Who this might be right for
Advanced/ Metastatic Solid Tumors
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 78
Not applicableActive Not RecruitingNCT07316439
What this trial is testing

Comparison Between ER Loss and Triple-Negative Breast Cancer Guided by 18F-FES PET/CT in Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Fudan University 197
Testing effectiveness (Phase 2)Looking for participantsNCT06387628
What this trial is testing

LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Fudan University 74
Testing effectiveness (Phase 2)Active Not RecruitingNCT03808662
What this trial is testing

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Who this might be right for
TNBC - Triple-Negative Breast CancerTriple Negative Breast CancerNSCLC+4 more
Memorial Sloan Kettering Cancer Center 107
Early research (Phase 1)Study completedNCT04664829
What this trial is testing

The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC

Who this might be right for
Metastatic Triple-Negative Breast Carcinoma
National Cancer Centre, Singapore 12
Testing effectiveness (Phase 2)Looking for participantsNCT06880029
What this trial is testing

Circadian Rhythm Impact on TNBC Response to Neoadjuvant Immunotherapy

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. 20
Large-scale testing (Phase 3)UnknownNCT03876886
What this trial is testing

The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency

Who this might be right for
Triple Negative Breast Cancer
Chinese Academy of Medical Sciences 200
Testing effectiveness (Phase 2)Looking for participantsNCT05660083
What this trial is testing

Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

Who this might be right for
HER2-negative Breast CancerMetastatic Breast CancerMetaplastic Breast Carcinoma+1 more
The Methodist Hospital Research Institute 36
Testing effectiveness (Phase 2)UnknownNCT04755868
What this trial is testing

Talazoparib Maintenance Therapy in Triple-negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Yonsei University 206
Testing effectiveness (Phase 2)Looking for participantsNCT06401005
What this trial is testing

SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)

Who this might be right for
Breast Cancer
Hubei Cancer Hospital 51
Testing effectiveness (Phase 2)Study completedNCT02435680
What this trial is testing

Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC)

Who this might be right for
Advanced Triple Negative Breast Cancer (TNBC) With High TAMs
Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07419880
What this trial is testing

Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer

Who this might be right for
Triple -Negative Breast Cancer
Fudan University 46
Not applicableLooking for participantsNCT07067138
What this trial is testing

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

Who this might be right for
Breast CancerBreast CarcinomaCancer of the Breast+1 more
National Cancer Institute (NCI) 175
Testing effectiveness (Phase 2)WithdrawnNCT03872505
What this trial is testing

Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast Cancer
Cedars-Sinai Medical Center
Large-scale testing (Phase 3)Not Yet RecruitingNCT07760844
What this trial is testing

An Open-Label, Randomized Phase III Study of Trastuzumab Rezetecan With or Without Everolimus in First to Third Line LAR Subtype TNBC

Who this might be right for
Breast CancerTriple Negative Breast Cancer (TNBC)
Fudan University 180
Large-scale testing (Phase 3)Study completedNCT03125902
What this trial is testing

Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)

Who this might be right for
Triple-Negative Breast Cancer
Hoffmann-La Roche 653
Not applicableNot Yet RecruitingNCT07551765
What this trial is testing

Diet-drive Gut Microbiome and Outcome in Patients With Early-stage Triple-negative Breast Cancer Undergoing Neoadjuvant Chemotherapy and Immunotherapy.

Who this might be right for
Triple Negative Breast Cancer (TNBC), Early Setting
Barts & The London NHS Trust 300
Not applicableLooking for participantsNCT07622836
What this trial is testing

A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer.

Who this might be right for
TNBCAdjuvant TherapyLymph Node Positive
The First Affiliated Hospital with Nanjing Medical University 59
Early research (Phase 1)Study completedNCT03454451
What this trial is testing

CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers

Who this might be right for
Non-Small Cell Lung CancerRenal Cell CancerColorectal Cancer+10 more
Corvus Pharmaceuticals, Inc. 117
Next Page